Author: Andrew P. Han

University investigation finds misconduct by bone researcher with 23 retractions

Hirosaki University

As a bone researcher continues to accrue retractions, an investigation at his former university has found misconduct in more than a dozen papers.

On Nov. 15, Japan’s Hirosaki University announced it had identified fabrication and authorship issues in 13 papers by Yoshihiro Sato, and plagiarism in another.

Sato, a professor at Hirosaki University Medical School from 2000 to 2003, died in January. He was last affiliated with Mitate Hospital. Multiple retractions in recent months have pushed Sato higher up our leaderboard; by our count, he now has 23 retractions and the university said there are likely more to come. Continue reading University investigation finds misconduct by bone researcher with 23 retractions

Brazil research foundation sues scientist over $103k scholarship

The São Paulo Research Foundation (FAPESP), a state-level agency in Brazil that funds scientific research, is suing Paty Karoll Picardi, a protégé of Brazilian diabetes researcher Mario Saad.

According to a São Paulo Court of Justice website, the reason stated is for “recebimento of bolsa de estudos,“ which translates to “receipt of scholarship.” FAPESP is suing for 334,116 Brazilian Reals ($102,927).

Now, Picardi is counter-suing, according to a case document released Nov. 17 — although we’re not sure for what, and why.  Continue reading Brazil research foundation sues scientist over $103k scholarship

New York psychiatry researcher charged with embezzlement, faces jail time

Alexander Neumeister. Source: Yale School of Medicine

A researcher specializing in post-traumatic stress disorder is facing jail time for allegedly embezzling tens of thousands of dollars of federal grant money.

Yesterday, the US Attorney’s Office for the Southern District of New York and the U.S. Department of Health and Human Services’s Office of Inspector General (OIG) announced criminal charges against Alexander Neumeister, alleging he used the grant funds on trips and meals for family and friends. As the New York Times reported last year, Neumeister was dismissed from his position at New York University (NYU); NYU shut down eight of his studies following an investigation by the U.S. Food and Drug Administration, which found evidence of lax oversight, falsified records, and inaccurate case histories. 

The U.S. Attorney has also filed a civil lawsuit against Neumeister under the False Claims Act, also for misuse of grant funding. The complaint does not specify the total amount of funds he allegedly misused.

In a statement, Acting U.S. Attorney Joon Kim said Neumeister:

Continue reading New York psychiatry researcher charged with embezzlement, faces jail time

US court issues injunction against OMICS to stop “deceptive practices”

A US government agency has won an initial court ruling against OMICS, which the government says will help stop the academic publisher’s deceptive business practices.

Today, the Federal Trade Commission (FTC) announced that it won a preliminary injunction in September in its lawsuit against Srinubabu Gedela, CEO of OMICS Group and other companies.

The lawsuit, filed in August 2016, accused the defendants — which include Gedela and OMICS Group, iMedPub, and Conference Series — of deceptive business practices related to journal publishing and scientific conferences. The FTC alleged the defendants used the names of prominent researchers to draw conference attendees, even though the researchers had not agreed to participate; misled readers about whether articles had been peer reviewed; failed to provide authors with transparent information about publishing fees prior to submission; and presented misleading “impact factors” for journals.

On Sept. 29, Judge Gloria Navarro of the US District Court for the District of Nevada, wrote that evidence submitted by the FTC “is sufficient to support a preliminary conclusion that Defendants made misrepresentations regarding their journal publishing” and conferences, and: Continue reading US court issues injunction against OMICS to stop “deceptive practices”

Journal replaces anti-vaccine paper it retracted for missing conflicts, “number of errors”

A journal retracted a paper about how conflicts of interest might be influencing research into the link between vaccines and autism because — wait for it — the authors failed to disclose conflicts of interest.

According to the retraction notice, the editors retracted the paper without the authors’ agreement, because the authors had a host of personal and professional interests in the field they didn’t declare, such as being associated with organizations involved in autism and vaccine safety. What’s more, the article also contained “a number of errors, and mistakes of various types that raise concerns about the validity of the conclusion.”

But now, Science and Engineering Ethics has published a new version of the article that draws similar conclusions to the retracted one, albeit with an updated conflict of interest statement, among other changes. From the abstract of the revised version: Continue reading Journal replaces anti-vaccine paper it retracted for missing conflicts, “number of errors”

Lawyers call libel suit against journal and critic “lawless” but “well written”

Mark Jacobson

A $10 million defamation suit filed by a Stanford University professor against a critic and a journal may be an assault on free speech, according to one lawyer, but at least it’s “well written.”

Kenneth White, a lawyer at Southern California firm Brown White & Osborn who frequently blogs about legal issues related to free speech at Popehat, told us:

It’s not incompetently drafted, but it’s clearly vexatious and intended to silence dissent about an alleged scientist’s peer-reviewed article.

Scientists have publicly bemoaned the suit’s existence, as reported by several outlets, including Mashable and Nature. Mark Jacobson, an engineering professor at Stanford, has alleged that he was defamed in a June article published in the Proceedings of the National Academy of Sciences (PNAS), which was critical of a 2015 paper co-authored by Jacobson in the same journal. In a complaint filed Sept. 29 in the Superior Court of the District of Columbia, Jacobson accused the journal’s publisher, the National Academy of Sciences, and the paper’s first author, Christopher Clack, an executive at a renewable energy analysis firm, of libel.

White told us that there are several pitfalls that could trip up the lawsuit, including a DC law that allows defendants an early opportunity to ask the court to dismiss cases muzzling free speech and recover attorneys’ fees. But another attorney said the complaint should at least clear the lowest hurdle in the way of getting to trial. Continue reading Lawyers call libel suit against journal and critic “lawless” but “well written”

Researchers ask to retract cancer paper five days after it’s flagged by journal

Researchers from the University of Kansas asked to retract their paper only days after the journal issued an expression of concern related to some of the images.

The retraction notice marks the close of an episode that started in June, but it doesn’t provide much closure: Figures in the paper apparently do not match primary data, but there’s no hint as to how that happened.

In a statement sent to JCS — just five days after the expression of concern came out — last author Kristi Neufeld, a cancer biologist at KU, wrote: Continue reading Researchers ask to retract cancer paper five days after it’s flagged by journal

Senior NOAA appointee calls for retraction of paper on illegal fishing

Chris Oliver

A top US official at the National Oceanic and Atmospheric Administration, who was recently appointed by President Donald Trump, has called for the retraction of a paper that suggests the country exports a significant amount of illegal, unreported, and unregulated fishing.

The paper, published July 6 in Marine Policy, estimated that in 2015 approximately one-fifth of Alaska pollock exports to Japan were either illegal, unreported, or unregulated — a value of as much as $75 million.

In an Oct. 11 letter (first reported by IntraFish), Chris Oliver, NOAA assistant administrator for fisheries, criticized the paper’s methodology for calculating the illegal hauls.

Oliver wrote to the journal’s editor-in-chief to say that the National Marine Fisheries Service: Continue reading Senior NOAA appointee calls for retraction of paper on illegal fishing

More duplications for researcher accused of misconduct in lawsuit

Despite losing a lawsuit against his former mentor, a researcher hasn’t stopped his efforts to discredit his mentor’s work. These efforts have led to new editorial notices — including, most recently, a correction and expression of concern for one paper by a former colleague, who wasn’t even the subject of the lawsuit.

In the 2014 suit, former Brown University postdoc Andrew Mallon said research misconduct by John Marshall — his lab director and former business partner– tainted a 2013 paper published in PLoS Biology. Though the case failed to trigger the retraction Mallon sought, it put his concerns into the public record; the text of the lawsuit includes an accusation of misconduct against Cong Cao — Marshall’s former mentee and the first author of that 2013 paper.

Mallon has since contacted journals to raise concerns about papers by Cao, and two journals have taken action. The most recent move: On Aug. 10, the Biochemical Journal did something we don’t see very often — it issued both a correction and an expression of concern (EoC) for one of Cao’s papers: “EGFR-mediated expression of aquaporin-3 is involved in human skin fibroblast migration,” originally published Nov. 14, 2006. Continue reading More duplications for researcher accused of misconduct in lawsuit

Science retracts paper after Nobel laureate’s lab can’t replicate results

Science is retracting a 2014 paper from the lab of a Nobel winner after replication attempts failed to conclusively support the original results.

In January, Bruce Beutler, an immunologist at University of Texas Southwestern Medical Center and winner of the 2011 Nobel Prize in Physiology or Medicine, emailed Science editor-in-chief Jeremy Berg to report that attempts to replicate the findings in “MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses” had weakened his confidence in original results. The paper had found that virus-like elements in the human genome play an important role in the immune system’s response to pathogens.

Although Beutler and several co-authors requested retraction right off the bat, the journal discovered that two co-authors disagreed, which Berg told us drew out the retraction process. In an attempt to resolve the situation, the journal waited for Beutler’s lab to perform another replication attempt. Those findings were inconclusive and the dissenting authors continued to push back against retraction.

Berg told us:

Continue reading Science retracts paper after Nobel laureate’s lab can’t replicate results